Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers

Summary

A Multicenter, Randomized, Single-Blind Study with an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers

Timeline

Start

2015-10

Primary completion

2017-04

Completion

2017-06

Outcome

Outcome not reported

Stopped: “Company's desire to allocate more research and development resources to other clinical programs. Decision not driven by any safety concerns.”

Drugs

Indications